Overcoming Barriers to Biologics Innovation explores the growing importance of biologics in treating cancer, rare diseases, and chronic conditions, alongside the rising complexity of their discovery. While biologics offer strong safety profiles and breakthrough potential, innovation is slowed by diversified modalities, complex structures, intricate workflows, and disconnected systems. The paper identifies these barriers and outlines how an integrated, data-driven approach can address them. It highlights the Dotmatics Biologics Discovery solution as a way to unify data, streamline workflows, and support collaboration across teams. Real-world examples demonstrate improved efficiency and decision-making, while practical guidance helps teams modernize biologics discovery and accelerate innovat

Join for free to read